Perspective TherapeuticsFRA:AAJ0 +3.72%31 Days Payable is 0.00 as of Mar. 2026. GuruFocus rates FRA:AAJ0 with a GF Score™ of 31/100. The stock has 1 warning sign investors should review. Among 795 Medical Devices & Instruments companies, Perspective Therapeutics ranks worse than 125786.04% on this metric.
The historical rank and industry rank for Perspective Therapeutics's Days Payable or its related term are showing as below:
During the past 13 years, Perspective Therapeutics's highest Days Payable was 90.38. The lowest was 43.66. And the median was 53.56.
FRA:AAJ0's Days Payable is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 67.87 * Ranked among companies with meaningful Days Payable only.
Perspective Therapeutics's Days Payable
stayed the same
from Mar. 2025 (0.00) to Mar. 2026 (0.00).
stayed the same
Perspective Therapeutics Days Payable Related Terms
Perspective Therapeutics Days Payable Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:AAJ0 vs LAB, KIDS, PACB: Days Payable Comparison
For the Medical Devices subindustry, Perspective Therapeutics's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Perspective Therapeutics Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Perspective Therapeutics's Days Payable distribution charts can be found below:
* The bar in red indicates where Perspective Therapeutics's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Perspective Therapeutics's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Perspective Therapeutics (FRA:AAJ0) has a Days Payable of 0.00 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Perspective Therapeutics and its competitors. Over the past decade, Perspective Therapeutics' Days Payable has ranged from 43.66 to 90.38. According to the industry distribution chart, Perspective Therapeutics ranks #999999 out of 795 companies in the Medical Devices & Instruments industry.
Is Perspective Therapeutics' Days Payable too high?
Perspective Therapeutics' current Days Payable is 0.00. Over the past 10 years, this metric has ranged from a low of 43.66 to a high of 90.38. Based on the distribution chart, Perspective Therapeutics ranks #999999 out of 795 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Perspective Therapeutics has a GF Score™ of 31/100, reflecting its overall financial health beyond just this single metric.
How does Perspective Therapeutics' Days Payable compare to LAB and KIDS?
According to the Medical Devices & Instruments industry distribution chart, Perspective Therapeutics ranks #999999 out of 795 companies for Days Payable. This places Perspective Therapeutics in the lower half of its industry. The industry median Days Payable is 67.87. Historically, Perspective Therapeutics' own Days Payable has ranged from 43.66 to 90.38 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 67.87, based on 795 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Perspective Therapeutics and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 67.87 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Perspective Therapeutics's current Days Payable is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Perspective Therapeutics stock overvalued right now?
Perspective Therapeutics (FRA:AAJ0) has a current Days Payable of 0.00. The current Days Payable is 0.00. Perspective Therapeutics' overall GF Score™ is 31/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Perspective Therapeutics (FRA:AAJ0), the current Days Payable is 0.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.
31GF Score
Get the complete analysis for FRA:AAJ0
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:AAJ0 has been successfully added to your 
